[O5] Oral Presentations 5

5:10 PM - 5:20 PM JST(8:10 AM - 8:20 AM UTC)Clinical Research

[O5-02] Development of a novel oncolytic herpes virus with reduced tumor swelling for malignant glioma

*Tomoki Todo¹, Hirotaka Ito¹, Minoru Tanaka¹ (1. The Institute of Medical Science, The University of Tokyo (Japan))

Keywords:

oncolytic virus therapy,herpes simplex virus type 1,malignant glioma,bevacizumab

Password required to view

Log in

or